Obesity Drug by Arena Has an Effect, but a Limited One

Producing results it said would be good enough for regulatory approval, Arena Pharmaceuticals said its experimental obesity drug had succeeded in its first late-stage clinical trial.

Original post by By ANDREW POLLACK

Near-Term Babies May Face a Higher Risk of Problems

Babies born just three to six weeks before their due dates are more likely than full-term babies to have disabilities or developmental delays in kindergarten, a study found.

Original post by By RONI CARYN RABIN